Feature Channels: Substance Abuse

Filters close
Released: 4-May-2023 11:30 AM EDT
Government of Canada invests $6.5 million in research to support the health and mental wellbeing of young children
Canadian Institutes of Health Research (CIHR)

The Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced an investment of $6.5 million over five years for six projects funded through the Canadian Institutes of Health Research (CIHR) Mental Health in the Early Years (MHITEY) initiative. MHITEY, led by the CIHR’s Institute of Human Development, Child and Youth Health, will help to advance Canada’s mental health strategy by identifying solutions for safe and equitable programs and services for diverse populations, and through adopting, adapting and improving the use of evidence-based practices in clinical, community, and public health settings.

Newswise: Discovery suggests route to safer pain medications
2-May-2023 3:00 PM EDT
Discovery suggests route to safer pain medications
Washington University in St. Louis

Strategies to treat pain without triggering dangerous side effects such as euphoria and addiction have proven elusive. Now scientists at Washington University School of Medicine have identified a potential pathway to pain relief that neither triggers addiction nor causes hallucinations.

Released: 3-May-2023 10:10 AM EDT
Few Waivered Clinicians Prescribed Buprenorphine: New Study
George Washington University

A new study found a declining proportion of DATA-waivered clinicians prescribed any buprenorphine between 2017 and 2021. While the number of waivered clinicians increased significantly during the five-year window, only one out of three prescribed any buprenorphine as of May 2021. Furthermore, the majority of prescriptions were written by clinicians who specialize in treating opioid use disorder. The new study was published as a research letter in JAMA.

Released: 2-May-2023 1:40 PM EDT
How hallucinogenic substance in psilocybin mushrooms works on the molecular level
University of Southern Denmark

Psilocybin is a hallucinogenic compound found in about 200 mushroom species, including the liberty cap (Psilocybe semilanceata).

   
Released: 1-May-2023 1:00 PM EDT
Expert calls for reforms to address the overdose crisis
Mass General Brigham

At the end of 2022, the federal government eliminated the “X waiver,” a major hurdle to providing addiction treatment, but progress needs to be continued, according to the authors of a new Perspective piece published in the New England Journal of Medicine.

Released: 27-Apr-2023 6:55 PM EDT
Connect, Unplug and Do Good: Wellness Tips for Substance Use and Mental Health Recovery
Rutgers University-New Brunswick

Wellness is big business, and every year millions of people commit to living happier, healthier lives. But for people with substance use and mental health disorders, the concept of wellness isn’t a typical part of recovery. Margaret Swarbrick, professor and associate director of the Rutgers Center of Alcohol and Substance Use Studies, is working to change that. Her latest contribution, “Journey to Wellness,” is an easy-to-use 20-page guide co-created with people in recovery.

   
Released: 27-Apr-2023 6:55 PM EDT
Trauma-Informed Education Could Improve Outcomes for Justice-Involved Black Adolescents
Rutgers University-New Brunswick

Sexual and substance use education that incorporates knowledge about trauma could improve developmental outcomes among justice-involved Black youth, according to a Rutgers study published in the journal Children and Youth Services Review.

   
Released: 25-Apr-2023 5:05 PM EDT
Estimated 6.5 million Californians know someone at risk of harming themselves, others
UC Davis Health

One in five adults in California, or an estimated 6.5 million people, are concerned that someone they know, usually a friend or family member, is at risk of harming themselves or others, according to new research published in Preventive Medicine. Alcohol and substance misuse, a history of violence, and firearm access were common reasons for concerns about potential violence.

Released: 25-Apr-2023 12:05 PM EDT
Study: Treatment for opioid addiction lags despite policies designed to increase it
Michigan Medicine - University of Michigan

Treating opioid addiction should be much easier now than it was a few years ago, thanks to pandemic-era rule changes that aim to improve access to buprenorphine, a medicine proven to help in recovery. But a new study shows prescriptions and adherence rates have remained flat.

Released: 24-Apr-2023 6:05 PM EDT
UCLA Health seeks participants for first-of-its-kind study using injectable buprenorphine to treat methamphetamine use disorder and opioid co-use
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health investigators are leading a new, six-city trial of injectable buprenorphine for treatment of methamphetamine use disorder in adults who also use opioids.

Newswise:Video Embedded live-event-for-april-21-sleeping-pill-reduces-levels-of-alzheimer-s-proteins
VIDEO
Released: 21-Apr-2023 3:10 PM EDT
TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer’s proteins
Newswise

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

       
Released: 21-Apr-2023 2:45 PM EDT
Finnish population-based study: Vulnerable groups were the least likely to uptake COVID-19 vaccination
University of Helsinki

A large-scale registry study in Finland has identified several factors associated with uptake of the first dose of COVID-19 vaccination. In particular, persons with low or no labor income and persons with mental health or substance abuse issues were less likely to vaccinate.

Released: 21-Apr-2023 10:05 AM EDT
Cerebral palsy patients at higher risk of receiving opioid prescriptions
Michigan Medicine - University of Michigan

Opioids are commonly prescribed as an all-purpose pain killer for patients with the condition

Newswise:Video Embedded even-worms-get-the-munchies
VIDEO
19-Mar-2023 11:05 AM EDT
Even Worms Get the Munchies
University of Oregon

A study, led by University of Oregon neuroscientist Shawn Lockery, points to worms as a useful tool for understanding more about the many roles that cannabinoids naturally play in the body. And it could help researchers develop better drugs that target this system.

   
Released: 18-Apr-2023 8:30 PM EDT
School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens
NIH National Institute on Drug Abuse (NIDA)

Researchers have identified a strong association between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse (taken in a way other than as directed by a clinician) by students in middle and high schools.

Released: 18-Apr-2023 2:00 PM EDT
When both mom and dad maltreat their child
Ohio State University

About one in five cases of child abuse and neglect is committed by both mothers and fathers, but nearly all the research attention has been focused on when just one parent is involved. A new study that aimed to shine a light on risk factors for mistreatment coming from both parents found some surprising results.

Released: 18-Apr-2023 6:00 AM EDT
هل تؤثر العقاقير أفيونية المفعول التي تُصرف بوصفة طبية على الوظائف الإدراكية لدى البالغين الأكبر سنًا؟
Mayo Clinic

قد يكون لاستخدام الأدوية أفيونية المفعول التي تُصرف بوصفة طبية تأثير سلبي على الوظائف الإدراكية لدى البالغين الأكبر سنًا، وذلك وفقًا لدراسة حديثة أجرتها مايو كلينك، نُشرت في مجلة الجمعية الأمريكية لطب الشيخوخة.

Released: 14-Apr-2023 7:40 PM EDT
Offering medications for opioid addiction to incarcerated individuals leads to decrease in overdose deaths
Boston Medical Center

New research from Boston Medical Center concluded that offering medications to treat opioid addiction in jails and prisons leads to a decrease in overdose deaths. Published in JAMA Network Open, the study also found that treating opioid addiction during incarceration is cost-effective in terms of healthcare costs, incarceration costs, and deaths avoided.



close
2.34904